Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Clinical trial NCT03081858 · COMPLETED

Trial details

NCT number: NCT03081858
Sponsor: Lipac Oncology LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Cell Transitional Non-Muscle Invasive Bladder Cancer Bladder Cancer Urinary Bladder Transitional Cell Carcinoma of the Bladder Urinary Bladder Neoplasms Urologic Neoplasms Urogenital Neoplasms Urinary Bladder Diseases Urologic Diseases

Start date: 2018-05-17
Primary completion: 2020-08-27
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.